14-Nov-2022
Download PDF
Omkar Pharmachem
Dear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in its meeting held on 14th November 2022 has considered and approved the following business:Unaudited Financial Results of the Company along with Statement of Assets and Liabilities Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30th September 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
